BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs

Author(s): Ilan Matok, Amalia Levy, Rafael Gorodischer, Eitan Lunenfeld, Yehuda Limony, Gideon Koren.

Journal Name: Current Drug Safety

Volume 6 , Issue 1 , 2011

Become EABM
Become Reviewer


We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.

Keywords: Pregnancy, malformations, medication, fetus, neonate, BeMORE, Drugs, central nervous system, corticosteroids, Clalit Health Services, Demog-ICD9 database, CDC, ORs, CIs, congenital malformations, neural tube, cardiovascular defects, abortion

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [40 - 42]
Pages: 3
DOI: 10.2174/157488611794480052

Article Metrics

PDF: 18